SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (74)7/28/1999 5:48:00 PM
From: dalroi  Read Replies (1) of 427
 
When indeed there was a 1 billion short position
this issue would be solved very rapidly

glia could issue a 2 $ divident

then the shorters had to pay 2*1bilon$
to evry one who had glia shares in there account

or even better give out warrant eg 1 for each share owned
wrrant would make it possible to buy 1 share for 15 *
and 1 share for 20$ and then one for 25$ and another for 30$

this has a dual advantage
1/ glia gets all the funding it needs
2/ shorters realy bite to dust because now there not only short shares but for evry share a waarant which lets you buy 5 glia shares at different levels
3/ if we excersise our warants there is no dillution and we get a hell of a shortsqueese

DID YOU KNOW THAT the clearingshouse is ultimatly responsible for the shorts it let create ?

if glia comes out with this plan ( i copied it from a firm called tigershark ticker jaws) (only way it didnt work there was because owner printed shares so increased float by 4 times)

i'll by put on the trading houses which allowed shorts

ANYWAY ONE SHOULD REALY read yahoo ipo jaws or tgsk thread very instructive

we could however also call all ower certificates which would create havock in dtc and TA hehehehe :-)

Stefaan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext